Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 2
1954 1
1959 1
1960 2
1961 2
1963 2
1964 1
1965 1
1967 3
1968 1
1970 1
1971 2
1977 1
1979 1
1980 1
1981 1
1983 1
1988 3
1995 1
1996 1
1997 1
1998 2
1999 4
2000 5
2001 5
2002 4
2003 10
2004 6
2005 7
2006 7
2007 3
2008 7
2009 4
2010 11
2011 4
2012 6
2013 11
2014 10
2015 8
2016 13
2017 11
2018 2
2019 5
2020 10
2021 8
2022 5
2023 8
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Results by year

Filters applied: . Clear all
Page 1
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1).
Papp K, Reich K, Leonardi CL, Kircik L, Chimenti S, Langley RG, Hu C, Stevens RM, Day RM, Gordon KB, Korman NJ, Griffiths CE. Papp K, et al. Among authors: day rm. J Am Acad Dermatol. 2015 Jul;73(1):37-49. doi: 10.1016/j.jaad.2015.03.049. J Am Acad Dermatol. 2015. PMID: 26089047 Free article. Clinical Trial.
Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2).
Paul C, Cather J, Gooderham M, Poulin Y, Mrowietz U, Ferrandiz C, Crowley J, Hu C, Stevens RM, Shah K, Day RM, Girolomoni G, Gottlieb AB. Paul C, et al. Among authors: day rm. Br J Dermatol. 2015 Dec;173(6):1387-99. doi: 10.1111/bjd.14164. Epub 2015 Nov 7. Br J Dermatol. 2015. PMID: 26357944 Clinical Trial.
Erythropoietin Regulation by Angiotensin II.
Kim YC, Mungunsukh O, Day RM. Kim YC, et al. Among authors: day rm. Vitam Horm. 2017;105:57-77. doi: 10.1016/bs.vh.2017.02.001. Epub 2017 Mar 27. Vitam Horm. 2017. PMID: 28629525 Review.
Episensitization: Defying Time's Arrow.
Oronsky BT, Oronsky AL, Lybeck M, Oronsky NC, Scicinski JJ, Carter C, Day RM, Rodriguez Orengo JF, Rodriguez-Torres M, Fanger GF, Reid TR. Oronsky BT, et al. Among authors: day rm. Front Oncol. 2015 Jun 11;5:134. doi: 10.3389/fonc.2015.00134. eCollection 2015. Front Oncol. 2015. PMID: 26125013 Free PMC article. Review.
Microporous Biodegradable Films Promote Therapeutic Angiogenesis.
Hendow EK, Moazen M, Iacoviello F, Bozec L, Pellet-Many C, Day RM. Hendow EK, et al. Among authors: day rm. Adv Healthc Mater. 2020 Sep;9(17):e2000806. doi: 10.1002/adhm.202000806. Epub 2020 Jul 14. Adv Healthc Mater. 2020. PMID: 32666663 Free PMC article.
Biomaterials for hollow organ tissue engineering.
Hendow EK, Guhmann P, Wright B, Sofokleous P, Parmar N, Day RM. Hendow EK, et al. Among authors: day rm. Fibrogenesis Tissue Repair. 2016 Mar 23;9:3. doi: 10.1186/s13069-016-0040-6. eCollection 2016. Fibrogenesis Tissue Repair. 2016. PMID: 27014369 Free PMC article. Review.
194 results